Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomi...

by Swain, S. M., Baselga, J., Miles, D., Im, Y.-H., Quah, C., Lee, L. F., Cortés, J.
Published 2014

Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment

by Park, Y H, Jung, H A, Choi, M K, Chang, W, Choi, Y L, Do, I-g, Ahn, J S, Im, Y-H
Published 2014

Clinical significance of CD151 overexpression in subtypes of invasive breast cancer

by Kwon, M J, Park, S, Choi, J Y, Oh, E, Kim, Y J, Park, Y-H, Cho, E Y, Kwon, M J, Nam, S J, Im, Y-H, Shin, Y K, Choi, Y-L
Published 2012